"Cork-based indigenous pharmaceutical manufacturing companies have said that they are now having to establish new plants in the United States in a bid to protect jobs at home, in light of Donald Trump's ongoing aggressive tariff policy."
"With concerns about the price of imported drugs from factories in Ireland impacting demand, many Irish firms are now looking to establish a strong base on the other side of the Atlantic."
Cork-based pharmaceutical companies are responding to tariff concerns by building manufacturing plants in the United States. This move aims to safeguard jobs in Ireland amid fears that tariffs will affect the demand for imported drugs. The aggressive tariff policy under Donald Trump has prompted these firms to seek a more stable manufacturing base in the US, reflecting a significant shift in their operational strategies to maintain competitiveness and job security.
Read at Independent
Unable to calculate read time
Collection
[
|
...
]